Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, offers her perspective on the regulatory landscape and its impact on pharmaceutical engagement in social media in a new Pharmaceutical Executive feature.
With social media influencing patient conversations in 85% of clinical visits, pharmaceutical companies need a strategic approach that supports commercial goals while navigating the regulatory landscape governing digital promotion.
Harakal’s insights are particularly timely, as the U.S. Senate deliberates on legislation that may clarify regulatory oversight of pharmaceutical influencer marketing—highlighting the critical role of regulatory teams in shaping proactive, risk-conscious digital strategies.
